Squarepoint’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.24M | Buy |
222,036
+120,342
| +118% | +$1.16M | ﹤0.01% | 1949 |
|
|
2026
Q1 | $755K | Buy |
101,694
+69,380
| +215% | +$730K | ﹤0.01% | 3009 |
|
|
2025
Q4 | $380K | Sell |
32,314
-61,408
| -66% | -$663K | ﹤0.01% | 3434 |
|
|
2025
Q3 | $724K | Sell |
93,722
-641,751
| -87% | -$4.5M | ﹤0.01% | 2926 |
|
|
2025
Q2 | $5.38M | Buy |
735,473
+523,407
| +247% | +$4.22M | 0.01% | 1412 |
|
|
2025
Q1 | $2.01M | Buy |
212,066
+195,329
| +1,167% | +$2.44M | ﹤0.01% | 2087 |
|
|
2024
Q4 | $276K | Buy |
+16,737
| New | +$260K | ﹤0.01% | 4219 |
|
|
2024
Q3 | – | Sell |
-37,266
| Closed | -$517K | – | 4498 |
|
|
2024
Q2 | $517K | Buy |
+37,266
| New | +$528K | ﹤0.01% | 3055 |
|
|
2024
Q1 | – | Sell |
-20,126
| Closed | -$326K | – | 4402 |
|
|
2023
Q4 | $326K | Sell |
20,126
-17,488
| -46% | -$286K | ﹤0.01% | 3299 |
|
|
2023
Q3 | $463K | Sell |
37,614
-132
| -0.3% | -$1.96K | ﹤0.01% | 2847 |
|
|
2023
Q2 | $607K | Sell |
37,746
-96,433
| -72% | -$1.59M | ﹤0.01% | 2494 |
|
|
2023
Q1 | $2.34M | Buy |
134,179
+76,611
| +133% | +$1.09M | 0.01% | 1330 |
|
|
2022
Q4 | $532K | Sell |
57,568
-189,481
| -77% | -$1.77M | ﹤0.01% | 2244 |
|
|
2022
Q3 | $2.13M | Buy |
247,049
+96,329
| +64% | +$957K | 0.01% | 1285 |
|
|
2022
Q2 | $1.23M | Sell |
150,720
-60,089
| -29% | -$574K | 0.01% | 1479 |
|
|
2022
Q1 | $2.56M | Buy |
+210,809
| New | +$4.44M | 0.01% | 1006 |
|
|
2021
Q1 | – | Sell |
-5,763
| Closed | -$310K | – | 3448 |
|
|
2020
Q4 | $310K | Buy |
+5,763
| New | +$260K | ﹤0.01% | 2183 |
|
|
2019
Q4 | – | Sell |
-78,928
| Closed | -$1.51M | – | 2693 |
|
|
2019
Q3 | $1.51M | Buy |
78,928
+61,547
| +354% | +$1.44M | 0.01% | 972 |
|
|
2019
Q2 | $381K | Sell |
17,381
-147,916
| -89% | -$3.25M | ﹤0.01% | 1818 |
|
|
2019
Q1 | $3.38M | Buy |
165,297
+76,055
| +85% | +$1.32M | 0.04% | 576 |
|
|
2018
Q4 | $1.13M | Buy |
89,242
+8,242
| +10% | +$123K | 0.01% | 877 |
|
|
2018
Q3 | $1.24M | Buy |
81,000
+52,500
| +184% | +$726K | 0.01% | 895 |
|
|
2018
Q2 | $374K | Buy |
+28,500
| New | +$314K | 0.01% | 1289 |
|
|
2017
Q1 | – | Sell |
-20,325
| Closed | -$174K | – | 1788 |
|
|
2016
Q4 | $174K | Buy |
+20,325
| New | +$174K | 0.01% | 1486 |
|
|
2016
Q3 | – | Sell |
-33,352
| Closed | -$268K | – | 1174 |
|
|
2016
Q2 | $268K | Buy |
+33,352
| New | +$267K | 0.02% | 784 |
|
|
2016
Q1 | – | Sell |
-21,200
| Closed | -$167K | – | 1358 |
|
|
2015
Q4 | $167K | Buy |
+21,200
| New | +$155K | 0.02% | 1046 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Squarepoint's NEO Position: Q2 2026 in Review
Squarepoint increased its NeoGenomics (NEO) stake by 118% in Q2 2026, buying an estimated $1.16M and bringing the position to 222,036 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1949.
Squarepoint first reported a position in NEO in Q4 2015 and has held it in 26 quarters since. The position peaked at $5.38M in Q2 2025. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Squarepoint held 222,036 shares of NeoGenomics worth $3.24M as of Q2 2026.
- Squarepoint bought 120,342 NeoGenomics shares in Q2 2026, an estimated $1.16M.
- NeoGenomics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #1949 holding.
- Squarepoint first reported a position in NeoGenomics in Q4 2015 and has held it in 26 quarters since.
- Squarepoint's NeoGenomics position peaked at $5.38M in Q2 2025.
- 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.